Efficacy and safety of sintilimab-based neoadjuvant regimens in patients with resectable gastric or gastroesophageal junction adenocarcinoma: a single-arm systematic review and meta-analysis.

Tyvyt (sintilimab) - Innovent Biologics, Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42703297

Jinbao Wei; Ruina Cai; Ruping Ni; Siheng Lian; Tingting Nan; Xiaohong Wu; Xiaoyun Ye; Yonglong Su; Yuhong Huang; Yumei Cai

Sep 8, 2026